The profile of precedex is such that respiratory drive is preserved unlike propofol, fentanyl, ketamine, and midazolam. Yet it still provides sedation, hypnosis, and analgesia.
Would it be fair to speculate that a more generalized use of precedex and the expiration of its patent in 2019 (current cost is $40/vial) driving its cost down will possibly make it dummy proof to the extent that providers like periodontist could safely administer deep sedation in their office?
Would it be fair to speculate that a more generalized use of precedex and the expiration of its patent in 2019 (current cost is $40/vial) driving its cost down will possibly make it dummy proof to the extent that providers like periodontist could safely administer deep sedation in their office?